Correlation Between Verrica Pharmaceuticals and Oncolytics Biotech

Can any of the company-specific risk be diversified away by investing in both Verrica Pharmaceuticals and Oncolytics Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verrica Pharmaceuticals and Oncolytics Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Verrica Pharmaceuticals and Oncolytics Biotech, you can compare the effects of market volatilities on Verrica Pharmaceuticals and Oncolytics Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verrica Pharmaceuticals with a short position of Oncolytics Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verrica Pharmaceuticals and Oncolytics Biotech.

Diversification Opportunities for Verrica Pharmaceuticals and Oncolytics Biotech

0.72

Correlation Coefficient

Verrica Pharmaceuticals  Oncolytics Biotech

Poor diversification

The 3 months correlation between Verrica and Oncolytics is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Verrica Pharmaceuticals and Oncolytics Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncolytics Biotech and Verrica Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verrica Pharmaceuticals are associated (or correlated) with Oncolytics Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncolytics Biotech has no effect on the direction of Verrica Pharmaceuticals i.e., Verrica Pharmaceuticals and Oncolytics Biotech go up and down completely randomly.

Pair Corralation between Verrica Pharmaceuticals and Oncolytics Biotech

Given the investment horizon of 90 days Verrica Pharmaceuticals is expected to generate 2.1 times less return on investment than Oncolytics Biotech. But when comparing it to its historical volatility, Verrica Pharmaceuticals is 1.19 times less risky than Oncolytics Biotech. It trades about 0.08 of its potential returns per unit of risk. Oncolytics Biotech is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  51.00  in Oncolytics Biotech on May 6, 2025 and sell it today you would earn a total of  37.00  from holding Oncolytics Biotech or generate 72.55% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Verrica Pharmaceuticals  vs.  Oncolytics Biotech

Verrica Pharmaceuticals

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Verrica Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain fundamental indicators, Verrica Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.

Oncolytics Biotech

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Oncolytics Biotech are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady fundamental indicators, Oncolytics Biotech showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Verrica Pharmaceuticals and Oncolytics Biotech

The main advantage of trading using opposite Verrica Pharmaceuticals and Oncolytics Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verrica Pharmaceuticals position performs unexpectedly, Oncolytics Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncolytics Biotech will offset losses from the drop in Oncolytics Biotech's long position.

The idea behind Verrica Pharmaceuticals and Oncolytics Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.